Alx Oncology Holdings Inc (NASDAQ:ALXO) – Experts See The Stock A Different Way Today

In today’s recent session, 0.62 million shares of the Alx Oncology Holdings Inc (NASDAQ:ALXO) have been traded, and its beta is 0.98. Most recently the company’s share price was $1.77, and it changed around $0.12 or 7.58% from the last close, which brings the market valuation of the company to $93.62M. ALXO at last check was trading at a discount to its 52-week high of $17.83, offering almost -907.34% off that amount. The share price’s 52-week low was $1.19, which indicates that the recent value has risen by an impressive 32.77% since then. We note from Alx Oncology Holdings Inc’s average daily trading volume that its 10-day average is 0.78 million shares, with the 3-month average coming to 1.04 million.

Alx Oncology Holdings Inc stock received a consensus recommendation rating of Hold, based on a mean score of 1.86. If we narrow it down even further, the data shows that 0 out of 7 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 3 recommended ALXO as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight. Alx Oncology Holdings Inc is expected to report earnings per share of -0.39 for the current quarter.

Alx Oncology Holdings Inc (NASDAQ:ALXO) trade information

Instantly ALXO has been showing a green trend so far today with a performance of 7.58% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.8700 on recent trading dayincreased the stock’s daily price by 5.35%. The company’s shares are currently up 6.29% year-to-date, but still up 11.64% over the last five days. On the other hand, Alx Oncology Holdings Inc (NASDAQ:ALXO) is -3.53% down in the 30-day period. We can see from the shorts that 7.6 million shares have been sold at a short interest cover period of 5.41 day(s).

The consensus price target as assigned by Wall Street analysts is $23, which translates to bulls needing to increase their stock price by 92.3% from its current value. Analyst projections state that ALXO is forecast to be at a low of $14 and a high of $38.

Alx Oncology Holdings Inc (ALXO) estimates and forecasts

Alx Oncology Holdings Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -73.63 percent over the past six months and at a 26.20% annual growth rate that is well above the industry average of 16.50%.

Forecasts for the next quarter put sales growth at 0.00%.

Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -50.98%.

ALXO Dividends

Alx Oncology Holdings Inc’s next quarterly earnings report is expected to be released in February.

Alx Oncology Holdings Inc (NASDAQ:ALXO)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 1.97% of Alx Oncology Holdings Inc shares, and 94.65% of them are in the hands of institutional investors. The stock currently has a share float of 96.55%. Alx Oncology Holdings Inc stock is held by 140.0 institutions, with VENBIO PARTNERS LLC being the largest institutional investor. By 2024-06-30, it held 19.3531% of the shares, which is about 9.7 million shares worth $58.49 million.

FMR LLC, with 15.5923% or 7.81 million shares worth $47.12 million as of 2024-06-30, holds the second largest percentage of outstanding shares.

Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF were the top two Mutual Funds as of Sep 30, 2024. The former held 984.59 shares worth $1.76 million, making up 1.87% of all outstanding shares. On the other hand, iShares Russell 2000 ETF held roughly 867.2 shares worth around $1.55 million, which represents about 1.64% of the total shares outstanding.